1-9 of 9
Keith L Dawson, DNP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-Reported Disease Burden and Age: Results from a National Patient Advocacy Survey of Patients with Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Keith L. Dawson, DNP, MS, Mark A. Price, MA, MD, Peggy Ann Torney, MS, Victor Gonzalez, MA, MS, Maria Sae-Hau, PhD, Elisa S. Weiss, PhD, Brennan Mange, BA, Carol Mansfield, PhD, Eydith J Comenencia-Ortiz, PhD, Anthony S Masaquel, PhD MPH, Arliene Ravelo, MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4778.
https://doi.org/10.1182/blood-2019-123644
Published: 2019
Journal Articles

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Tu My To, PhD, Keith L. Dawson, DNP, MS, Anthony S Masaquel, PhD MPH, Arpamas Seetasith, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4721.
https://doi.org/10.1182/blood-2019-123408
Published: 2019
Journal Articles

Nurse Treatment Preferences Survey for Intravenous Rituximab Infusion Versus Subcutaneous Rituximab Injection: A Real-World Study

Mitul D. Gandhi, MD, Sheila Shapouri, PharmD, MS, Arliene Ravelo, MPH, Lavanya Sudharshan, MS, Jamyia Clark, MPH, Keith L. Dawson, DNP, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5890.
https://doi.org/10.1182/blood-2019-123739
Published: 2019
Journal Articles

What Are Patients' Preferences and Satisfaction Regarding Modes of Administration for the Treatment of Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Follicular Lymphoma (FL)?

Mark Price, MA, MD, Arliene Ravelo, MPH, Elisa Weiss, PhD, Peggy Ann Torney, MS, Victor Gonzalez, MHC-LP, Maria Sae-Hau, PhD, Carol Mansfield, PhD, Eydith Comenencia-Ortiz, PhD, Miko Cunanan, BS, Anthony Masaquel, PhD MPH, Keith L Dawson, DNP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5897.
https://doi.org/10.1182/blood-2018-99-115327
Published: 2018
Journal Articles

How Time Spent on Rituximab Infusion Impacts Patient Satisfaction, Stress, Employment, and Caregiver Burden

Maxine D Fisher, PhD, Christopher Wallick, PharmD, Paul J Miller, PhD, Mark S Walker, PhD, Stephen Lash, PharmD, Keith L Dawson, DNP, Carolina M Reyes, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5666.
https://doi.org/10.1182/blood.V130.Suppl_1.5666.5666
Published: 2017
Journal Articles

Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L Dawson, DNP, MS, Xiaolei Zhou, MS, Christopher R. Flowers, MD, Charles M. Farber, MD PhD, John D Hainsworth, MD, James R Cerhan, MD PhD, Brian K Link, MD, Jonathan W Friedberg, MD
Journal: Blood
Blood (2014) 124 (21): 3044.
https://doi.org/10.1182/blood.V124.21.3044.3044
Published: 2014
Journal Articles

PET Compared With CT As a Prognosticator After Rituximab Induction Therapy In Follicular Lymphoma: Report From The National Lymphocare Study

Ida Wong-Sefidan, MD, Michelle Byrtek, PhD, Xiaolei Zhou, MS, Jonathan W. Friedberg, MD, Christopher Flowers, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Keith L Dawson, DNP, RN, Erin G. Reid, MD, MS
Journal: Blood
Blood (2013) 122 (21): 4245.
https://doi.org/10.1182/blood.V122.21.4245.4245
Published: 2013
Journal Articles

A Proposed Prognostic Model For Overall Survival In The Oldest Old (>80 Years Old) Follicular Lymphoma Patients

Chadi Nabhan, MD, FACP, Michelle Byrtek, PhD, Keith L Dawson, DNP, RN, Xiaolei Zhou, MS, Brian K Link, MD, Jonathan W. Friedberg, MD, Andrew D. Zelenetz, MD, PhD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD, MS
Journal: Blood
Blood (2013) 122 (21): 3058.
https://doi.org/10.1182/blood.V122.21.3058.3058
Published: 2013
Journal Articles

Early Relapse Of Follicular Lymphoma After R-CHOP Uniquely Defines Patients At High Risk For Death: An Analysis From The National Lymphocare Study

Carla Casulo, MD, Michelle Byrtek, PhD, Keith L. Dawson, DNP, RN, Xiaolei Zhou, MS, Charles Farber, MD, Christopher R. Flowers, MD, MS, John D. Hainsworth, MD, Brian K Link, MD, Andrew D. Zelenetz, MD, PhD, Jonathan W. Friedberg, MD
Journal: Blood
Blood (2013) 122 (21): 510.
https://doi.org/10.1182/blood.V122.21.510.510
Published: 2013